Overview
Neonatal tuberculosis (TB) is a serious infection acquired transplacentally, during birth, or postnatally from an infected mother or caregiver. It is a rare but potentially fatal condition in newborns.Diagnosis
Diagnosis in neonates is challenging due to nonspecific symptoms and difficulty in obtaining samples.
Nucleic acid amplification tests (NAATs) on respiratory and stool samples can be used for detecting pulmonary TB in children 1.
Lateral flow urine lipoarabinomannan assay (LF-LAM) is recommended for children with HIV 1.
Parallel testing of NAATs on respiratory and stool samples, or with LF-LAM in HIV-infected children, may improve diagnostic accuracy 1.
A microbiological reference standard (MRS) based on culture or a composite reference standard is used for accuracy assessment 1.Management
Management of neonatal TB requires prompt diagnosis and treatment with a multi-drug regimen.
Specific drug regimens and dosages for neonatal TB are not detailed in the provided abstracts.Special Populations
Pediatrics: Nucleic acid amplification tests (NAATs) on respiratory and stool samples are used for diagnosing pulmonary TB in children under 10 years of age 1. Lateral flow urine lipoarabinomannan assay (LF-LAM) is recommended for children with HIV 1.Key Recommendations
Low-complexity automated nucleic acid amplification tests (LC-aNAATs) on respiratory and stool samples can be used to detect pulmonary tuberculosis disease in children 1. (Evidence: Moderate)
Lateral flow urine lipoarabinomannan assay (LF-LAM) is recommended for use in children with HIV 1. (Evidence: Moderate)
Parallel use of LC-aNAAT on respiratory and stool specimens, or with LF-LAM on urine amongst children with HIV, may be used to improve diagnostic accuracy compared to each assay alone 1. (Evidence: Moderate)References
1 Olbrich L, Yang B, Poore H, Razid A, Sweetser B, Damkjær MW et al.. Parallel use of low-complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children. The Cochrane database of systematic reviews 2025. link